Masimo (NASDAQ:MASI) Updates FY 2025 Earnings Guidance

Masimo (NASDAQ:MASI) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 4.900-5.100 for the period, compared to the consensus estimate of 4.670. The company issued revenue guidance of -. Masimo also updated its FY 2024 guidance to 4.100-4.100 EPS.

Analyst Upgrades and Downgrades

MASI has been the subject of a number of research analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Masimo in a report on Wednesday, November 6th. Wells Fargo & Company increased their price objective on Masimo from $171.00 to $193.00 and gave the company an “overweight” rating in a research report on Wednesday, December 11th. BTIG Research boosted their price objective on Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a report on Monday, October 14th. Raymond James upped their target price on shares of Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a research report on Friday, December 27th. Finally, Piper Sandler lifted their price target on shares of Masimo from $180.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 18th. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $179.67.

Masimo Stock Performance

Shares of NASDAQ:MASI opened at $174.54 on Thursday. Masimo has a fifty-two week low of $101.61 and a fifty-two week high of $180.97. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. The company has a market capitalization of $9.34 billion, a price-to-earnings ratio of 120.37 and a beta of 1.01. The firm’s 50 day simple moving average is $168.86 and its 200 day simple moving average is $139.54.

Masimo (NASDAQ:MASI) last announced its quarterly earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.14. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The company had revenue of $504.60 million for the quarter, compared to analysts’ expectations of $502.87 million. During the same period last year, the firm posted $0.63 earnings per share. The business’s quarterly revenue was up 5.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Masimo will post 4.03 earnings per share for the current year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.